Detalles de la búsqueda
1.
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.
Clin Infect Dis
; 78(3): 746-755, 2024 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37972288
2.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep
; 73(8): 168-174, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421935
3.
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021-2022 Season, VISION Network.
J Infect Dis
; 228(2): 185-195, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36683410
4.
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
J Infect Dis
; 227(12): 1348-1363, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806690
5.
Influenza vaccine effectiveness against influenza-A-associated emergency department, urgent care, and hospitalization encounters among U.S. adults, 2022-2023.
J Infect Dis
; 2023 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041853
6.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(53): 1637-1646, 2023 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921274
7.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 352-358, 2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239634
8.
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 255-263, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176007
9.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
MMWR Morb Mortal Wkly Rep
; 71(13): 495-502, 2022 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35358170
10.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1335-1342, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264840
11.
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(4): 139-145, 2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085224
12.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1616-1624, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580430
13.
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1539-1544, 2021 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735425
14.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep
; 70(44): 1553-1559, 2021 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735426
15.
Variations in Electronic Nicotine Delivery System (ENDS) device types and association with cigarette quit attempts.
Prev Med
; 148: 106588, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33930433
16.
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021.
Am J Transplant
; 22(1): 306-314, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967121
17.
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders.
Influenza Other Respir Viruses
; 18(3): e13269, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38494192
18.
Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.
Vaccine
; 41(37): 5424-5434, 2023 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37479609
19.
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods.
JAMA Netw Open
; 6(3): e232598, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920396
20.
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study.
BMJ
; 379: e072141, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36191948